Comparing RWA Regulation Across Hong Kong, Singapore, and the US

Hong Kong's SFC, Singapore's MAS, and the US SEC all start from the same principle: a tokenized security is regulated as whatever it represents, not as a new asset class created by the technology. Where they differ is in structure — Hong Kong updated its guidance in 2023 to allow broader public distribution of tokenized securities that already qualify for public offer, Singapore applies its existing capital markets license framework directly to tokenized products alongside structured pilots like Project Guardian, and the US mostly channels private RWA offerings through Regulation D exemptions that restrict access to accredited investors. This is a general, educational comparison, not legal advice, and each regime continues to evolve.

The Shared Principle: Substance Over Technology

Across all three jurisdictions, regulators reject the idea that wrapping an asset in a token changes what it legally is. A tokenized bond is still a bond. A tokenized fund unit is still a fund unit. This "same activity, same risk, same regulation" logic, explicit in Hong Kong's SFC guidance and implicit in Singapore's technology-neutral reading of the Securities and Futures Act, also shows up in how the US treats tokenized securities as securities under existing federal law.

The practical result is similar in all three places: firms distributing tokenized RWA products need the license that already applies to that type of financial activity, and disclosure obligations tied to the underlying asset do not disappear because a blockchain is involved.

Side-by-Side Comparison

Where the Real Differences Show Up

The shared principle covers a lot, but three practical differences matter for anyone evaluating an RWA product across these jurisdictions.

How access is defined. Hong Kong and Singapore define non-public investor eligibility mainly through asset or income thresholds tied to an individual's financial profile. The US does the same through its accredited investor test, but layers on a further split between exemptions — Reg D's narrower, faster path versus Regulation A's broader, more disclosure-heavy path with a hard offering cap. None of the three route "how much you have" into "how safe the product is." The threshold decides who is presumed able to evaluate more complex disclosure, not who is protected from loss.

How public distribution has moved. Hong Kong made a deliberate, dated policy shift in 2023 to open tokenized securities distribution more broadly where the underlying instrument already qualifies for public offer. Singapore's framework has generally allowed public-offer-eligible tokenized products under the SFA without an equivalent single dated shift, alongside separate, more contained industry pilots. The US has not made a comparable broad opening for private RWA offerings; Reg D-based products remain structurally tilted toward accredited investors unless an issuer specifically uses a public-access route like Regulation A.

How pilots relate to commercial products. Singapore's Project Guardian and Hong Kong's Project Ensemble are both real, active initiatives, but they are collaborations between regulators and specific institutions to test use cases, not blanket certifications. A commercial RWA product that references either initiative should still be evaluated on its own licensing, disclosure, and structure — the pilot label does not substitute for reading who the parties in an RWA product are or checking the product's own documents.

Why the Differences Exist

The gap between these regimes is not accidental. Hong Kong and Singapore both regulate securities primarily through licensing bodies with rule-making power that can update guidance through circulars and policy statements — which is why Hong Kong could shift its tokenized securities distribution policy in a single 2023 announcement. The US system leans more heavily on a statutory exemption framework set by Congress and interpreted by the SEC, where changes to core thresholds like the accredited investor definition typically move slower and go through formal rulemaking.

This also explains why Hong Kong and Singapore have been comparatively faster to publish tokenization-specific guidance, while the US has mostly fit RWA products into exemption categories that existed before tokenization was a consideration. Neither approach is inherently more protective of investors — they are different regulatory architectures reaching a similar substance-over-technology conclusion by different paths.

What This Means When You Read an RWA Product

A product's jurisdiction tells you which access rules and licensing regime apply, but it does not tell you whether the product is good or safe. The broader RWA regulation landscape shapes who can participate and under what disclosure standard; it does not replace judging the underlying asset, manager, term, and exit on their own merits.

A practical approach that works across all three regimes:

1. Identify what the token actually represents (a share, bond, fund unit, or something else).
2. Identify which jurisdiction's rules govern the offering, and whether it is public or restricted to a defined investor category.
3. Confirm the distributing firm holds the license or registration that activity requires in that jurisdiction.
4. Read the product's own documents for underlying asset, term, exit, and risk — regulation tells you who can access the product, not what will happen to your money.

You can review how Bifu presents RWA product and regulatory access information at Bifu RWA.

FAQ

Which jurisdiction has the most restrictive rules for retail RWA access?

It depends on the specific product rather than the jurisdiction as a whole. The US structurally limits most private RWA offerings to accredited investors through Regulation D, while Hong Kong's 2023 guidance and Singapore's public-offer framework both allow broader retail access for tokenized securities that already qualify for public distribution outside of tokenization.

Do Hong Kong, Singapore, and the US recognize each other's investor accreditation?

No. Each jurisdiction applies its own definition and threshold, and qualifying as an accredited or professional investor in one does not automatically confer that status in another. An investor participating across jurisdictions generally needs to meet each regime's test separately.

Does a regulatory pilot like Project Guardian or Project Ensemble mean a product is government-approved?

No. These are structured collaborations between a regulator and specific financial institutions to test tokenization use cases, not a blanket approval or certification that applies to every commercial product referencing the initiative. Each product still needs to be evaluated on its own licensing and disclosure.

Is there a global standard for RWA regulation?

Not currently. Hong Kong, Singapore, and the US each apply their own securities laws to tokenized assets, following a broadly similar principle of regulating substance over technology, but the specific thresholds, licensing categories, and public-access rules differ and are set independently by each regulator.

This content is for educational purposes only and does not constitute financial, investment, legal, tax, or trading advice. RWA products involve risk, including possible loss of principal. Always review product documents and risk disclosures before participating.

Related Reading

• Go deeper on each regime: Hong Kong SFC rules for tokenized securities, Reg D and accredited investor rules in the US, and Singapore's MAS approach to tokenized assets.
• See the broader picture in the RWA regulation landscape.
• Start with what RWA is and why it is not guaranteed-return wealth management.